Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review

Introduction: The severity of COVID-19 may be correlated with the risk of liver injury development. An increasing number of studies indicate that degrees of hepatotoxicity has been associated with using some medications in the management of COVID-19 patients. However, limited studies had systematica...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in medicine Vol. 8; p. 731436
Main Authors:	Sodeifian, Fatemeh, Seyedalhosseini, Zahra Sadat, Kian, Naghmeh, Eftekhari, Mahya, Najari, Shaghayegh, Mirsaeidi, Mehdi, Farsi, Yeganeh, Nasiri, Mohammad Javad
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media SA 20.09.2021 Frontiers Media S.A
Subjects:	adverse drug reaction Antibiotics Case reports Cohort analysis COVID-19 Cross-sectional studies Disease drug induced liver injury (DILI) Fever Liver liver injury Medicine Pathogenesis Patients Pneumonia SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Side effects Systematic review Viral infections Italy Netherlands United States > US China Japan COVID-19 SARS-CoV-2 liver injury drug induced liver injury (DILI) adverse drug reaction
ISSN:	2296-858X, 2296-858X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!